J. M. D. Del Rosario

发表

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

J. Heeney, G. Carnell, Sneha Vishwanath, 2022, Vaccines.

Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design

J. Heeney, G. Carnell, R. Wagner, 2021, bioRxiv.

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

V. Sandig, J. Heeney, G. Carnell, 2023, Frontiers in Immunology.

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity

Y. Takeuchi, M. Collins, P. Risley, 2020, Frontiers in Immunology.

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

J. Heeney, G. Carnell, R. Wagner, 2021, Vaccines.

Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies

P. Kellam, G. Carnell, S. Scott, 2021, Frontiers in Immunology.

Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection

J. Heeney, G. Carnell, R. Wagner, 2021, bioRxiv.

AutoPlate: Rapid Dose-Response Curve Analysis for Biological Assays

J. Heeney, G. Carnell, D. Wells, 2022, Frontiers in Immunology.